Recurrent leishmaniasis in kidney transplant recipients: Report of 2 cases and systematic review of the literature

Transplant Infectious Disease

Volumn 13, Issue 4, 2011, Pages 397-406

  Simon, I ^a   Wissing, K M ^b   Del Marmol, V ^a   Antinori, S ^c   Remmelink, M ^a   Nilufer Broeders, E ^a   Nortier, J L ^a   Corbellino, M ^c   Abramowicz, D ^a   Cascio, A ^d  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cryoglobulinemia; Leishmania; Leishmaniasis; Tongue; Transplant; Vasculitis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; GADOLINIUM; IMMUNOSUPPRESSIVE AGENT; MEGLUMINE ANTIMONATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; AMASTIGOTE; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHEMOPROPHYLAXIS; CRYOGLOBULINEMIA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOPHTHALMITIS; ENTERITIS; FEVER; FOLLOW UP; GOUT; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HYPERACUTE GRAFT REJECTION; HYPERGAMMAGLOBULINEMIA; IMMUNOFLUORESCENCE TEST; INFLAMMATION; ITALY; KIDNEY FAILURE; KIDNEY GRAFT; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPH NODE; MALE; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURPURIC RASH; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RECURRENT INFECTION; SKIN LEISHMANIASIS; THROMBOCYTOPENIA; TONGUE ULCER; UNSPECIFIED SIDE EFFECT; VISCERAL LEISHMANIASIS;

ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LEG ULCER; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECURRENCE; TONGUE;

EID: 79961209346     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00598.x     Document Type: Article

References (45)

1. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
2. Cruz I, Morales MA, Noguer I, Rodriguez A, Alvar J. Leishmania in discarded syringes from intravenous drug users. Lancet 2002; 359: 1124-1125.
3. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 2008; 8: 191-199.
4. Pizzuto M, Piazza M, Senese D, et al. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol 2001; 39: 357-361.
5. van Eys GJ, Schoone GJ, Kroon NC, Ebeling SB. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol 1992; 51: 133-142.
6. Donovan KL, White AD, Cooke DA, Fisher DJ. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient. J Infect 1990; 21: 107-110.
7. Orofino L, Marcen R, Gamez C, et al. Visceral leishmaniasis in renal transplant patients. Nephrol Dial Transplant 1992; 7: 651.
8. Malek Hosseini SA, Javid R, Salahi H, Nezakatgoo N, Ahmad E, Ghahramani N. A case report of Kala-Azar in a kidney transplant patient. Transplant Proc 1995; 27: 2715.
9. Sharma RK, Jha R, Kumar P, et al. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems. Am J Nephrol 1996; 16: 358-360.
10. Apaydin S, Ataman R, Serdengect K, et al. Visceral leishmaniasis without fever in a kidney transplant recipient. Nephron 1997; 75: 241-242.
11. Boletis JN, Pefanis A, Stathakis C, Helioti H, Kostakis A, Giamarellou H. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome). Clin Infect Dis 1999; 28: 1308-1309.
12. Hernandez-Perez J, Yebra-Bango M, Jimenez-Martinez E, et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999; 29: 918-921.
13. Gontijo CM, Pacheco RS, Orefice F, Lasmar E, Silva ES, Melo MN. Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient. Mem Inst Oswaldo Cruz 2002; 97: 751-753.
14. Sabbatini M, Pisani A, Ragosta A, Gallo R, Borrelli F, Cianciaruso B. Visceral leishmaniasis in renal transplant recipient: is it still a challenge to the nephrologist? Transplantation 2002; 73: 299-301.
15. Oliveira CM, Oliveira ML, Andrade SC, et al. Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment. Transplant Proc 2008; 40: 755-760.
16. Oliveira RA, Silva LS, Carvalho VP, et al. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil. Transpl Infect Dis 2008; 10: 364-368.
17. Dettwiler S, McKee T, Hadaya K, Chappuis F, van Delden C, Moll S. Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction. Am J Transplant 2010; 10: 1486-1489.
18. Veroux M, Corona D, Giuffrida G, et al. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management. Transpl Infect Dis 2010; 12: 387-391.
19. Rousaud F, Sola R, Oliver A, Ayats R, Del Rio G. Recaida de leishmaniasis visceral (LV) tras terapia inmunosupresora antirrechazo en un paciente trasplantado de rinon. Buena evolucion a largo plazo. Nefrologya 1991; 11: 72-74.
20. Dunan S, Mary C, Gambarelli F, et al. [Four cases of visceral leishmaniasis in renal graft recipients: epidemiological and therapeutical reflexions]. Méd Malad Infect 1993; 23: 297-301.
21. Fernandez-Guerrero ML, Robles P, Rivas P, Mojer F, Muniz G, de Gorgolas M. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 2004; 90: 11-16.
22. World Health Organization. Control of the Leishmaniases. Technical Report Series No. 9793. Geneva: WHO, 1990.
23. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296-306.
24. Alrajhi AA, Saleem M, Ibrahim EA, Gramiccia M. Leishmaniasis of the tongue in a renal transplant recipient. Clin Infect Dis 1998; 27: 1332-1333.
25. Iborra C, Caumes E, Carriere J, Cavelier-Balloy B, Danis M, Bricaire F. Mucosal leishmaniasis in a heart transplant recipient. Br J Dermatol 1998; 138: 190-192.
26. Bern C, Adler-Moore J, Berenguer J, et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006; 43: 917-924.
27. Makni S, Zouiten F, Yalaoui S, et al. [Characterization and evolution of blood cryoglobulin in visceral leishmaniasis]. Bull Soc Pathol Exot 1992; 85: 164-166.
28. Casato M, de Rosa FG, Pucillo LP, et al. Mixed cryoglobulinemia secondary to visceral Leishmaniasis. Arthritis Rheum 1999; 42: 2007-2011.
29. Rizos E, Dimos G, Liberopoulos EN, Elisaf MS, Drosos AA. Cryoglobulinemic purpura in visceral leishmaniasis. Rheumatol Int 2005; 25: 469-471.
30. Bourgeois N, Lachaud L, Reynes J, Rouanet I, Mahamat A, Bastien P. Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis. J Acquir Immune Defic Syndr 2008; 48: 13-19.
31. Antinori S, Calattini S, Longhi E, et al. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis 2007; 44: 1602-1610.
32. Alvar J, Aparicio P, Aseffa A, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008; 21: 334-359.
33. Beltrame A, Arzese A, Camporese A, et al. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B. J Travel Med 2008; 15: 358-360.
34. Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Clin Infect Dis 2009; 48: e16-e22.
35. Ribera E, Ocana I, de Otero J, Cortes E, Gasser I, Pahissa A. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med 1996; 100: 496-501.
36. Angarano G, Maggi P, Coppola SL, Cavaliere RL. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1998; 17: 365-367.
37. Molina I, Falco V, Crespo M, et al. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother 2007; 60: 837-842.
38. Patel TA, Lockwood DN. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. Trop Med Int Health 2009; 14: 1064-1070.
39. Marques N, Sa R, Coelho F, Oliveira J, Saraiva Da Cunha J, Melico-Silvestre A. Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients. Scand J Infect Dis 2008; 40: 523-526.
40. Lima Verde FA, Lima Verde IA, Silva Junior GB, Daher EF, Lima Verde EM. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol 2007; 20: 430-436.
41. Salgado Filho N, Ferreira TM, Costa JM. [Involvement of the renal function in patients with visceral leishmaniasis (kala-azar)]. Rev Soc Bras Med Trop 2003; 36: 217-221.
42. Dutra M, Martinelli R, de Carvalho EM, Rodrigues LE, Brito E, Rocha H. Renal involvement in visceral leishmaniasis. Am J Kidney Dis 1985; 6: 22-27.
43. Agenor Araujo Lima Verde F, Araujo Lima Verde F, De Francesco Daher E, Martins Dos Santos G, Saboia Neto A, Mendoca Lima Verde E. Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar). Clin Nephrol 2009; 71: 492-500.
44. Alex S, Criado C, Fernandez-Guerrero ML, et al. Nephrotic syndrome complicating chronic visceral leishmaniasis: re-emergence in patients with AIDS. Clin Nephrol 2008; 70: 65-68.
45. Bourgeois N, Bastien P, Reynes J, Makinson A, Rouanet I, Lachaud L. 'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients. HIV Med 2010; 11: 670-673.